A Gene Therapy Platform for Targeting Cancer

Cancer is caused by malfunctions in the cell’s regulatory machinery leading to uncontrolled cell growth. At Onconetics, we use these regulatory differences to target the expression of a kill gene to attack cancer from within.

By harnessing the cell’s regulatory network of a cell, Onconetics’ therapeutic approach facilitates the highly specific targeting of cancer cells in order to mitigate side effects and enhance the quality of life for patients.

Redefining the Field through Expertise and Innovation

Onconetics is developing sophisticated gene therapies that allow for the targeted expression of therapeutic proteins. Its team of highly committed scientists, entrepreneurs, and business leaders are working to enable the future of gene therapy. Onconetics is a graduate of the IndieBio Accelerator Program and a member of Endless Frontier Labs at NYU Stern.
Leadership team
Business Advisors
Scientific Advisors

Keep in touch
with us!